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Environmental changes have an undoubted inﬂuence on the appearance, distribution, and
evolution of infectious diseases, and notably on those transmitted by vectors. Global change
refers to environmental changes arising from human activities affecting the fundamental
mechanisms operating in the biosphere. This paper discusses the changes observed in
recent times with regard to some important arboviral (arthropod-borne viral) diseases of
animals, and the role global change could have played in these variations. Two of the most
important arboviral diseases of animals, bluetongue (BT) and West Nile fever/encephalitis
(WNF), have been selected as models. In both cases, in the last 15 years an important
leap forward has been observed, which has lead to considering them emerging diseases
in different parts of the world. BT, affecting domestic ruminants, has recently afﬂicted
livestock in Europe in an unprecedented epizootic, causing enormous economic losses.
WNF affects wildlife (birds), domestic animals (equines), and humans, thus, beyond the
economic consequences of its occurrence, as a zoonotic disease, it poses an important
public health threat. West Nile virus (WNV) has expanded in the last 12 years worldwide,
and particularly in the Americas, where it ﬁrst occurred in 1999, extending throughout
the Americas relentlessly since then, causing a severe epidemic of disastrous conse-
quences for public health, wildlife, and livestock. In Europe, WNV is known long time
ago, but it is since the last years of the twentieth century that its incidence has risen
substantially. Circumstances such as global warming, changes in land use and water
management, increase in travel, trade of animals, and others, can have an important
inﬂuence in the observed changes in both diseases. The following question is raised:
What is the contribution of global changes to the current increase of these diseases in
the world?
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INTRODUCTION
Infectious disease can be viewed as a play involving at least two
characters: the pathogen and the host. While both roles can be
represented by a great variety of performers, pathogens exhibit by
far the highest variety and complexity. This review is about viral
infections in animals. It aims ﬁrst to give an idea of the enor-
mous complexity and diversity of the existing infectious agents,
emphasizing their extraordinary capacity for change and adapta-
tion, which eventually leads to the emergence of new infectious
diseases. Secondly, it focuses on the inﬂuence of the environment
in this process, and on how environmental (including climate)
changes occurring in recent times, have precise effects on the emer-
gence and evolution of infectious diseases, some of which will be
illustrated with speciﬁc examples. Finally, it describes the recent
and dramatic expansion of two of the most important emerging
animal viral diseases at present, bluetongue (BT) and West Nile
fever/encephalitis (WNF), dealing with their relationship to cli-
mate and other environmental changes, particularly those linked
to human activities, collectively known as“global change,” and that
can be at least in part seen a consequence of the “globalization”
phenomenon.
EMERGING VIRAL DISEASES OF ANIMALS
COMPLEXITY AND DIVERSITY OF ANIMAL VIRUSES
To illustrate the enormous complexity of animal viruses, consider
the following example: take any animal species, e.g., bovine. There
are ﬁve known species of herpesviruses that could infect bovines
speciﬁcally. Similarly, there are nine different known equine her-
pesviruses, eight human herpesviruses, and so on and so forth
(Pellet andRoizman,2007). Bearing inmind that there are approx-
imately 5,400 different species of mammals (Wilson and Reeder,
2005) and that most of them have yielded at least one, most fre-
quently several distinct herpesviruses on examination, the number
of existing mammalian herpesvirus species would be huge, prob-
ably in the range of thousands. But there are also herpesviruses
speciﬁc for birds, for reptiles, for amphibians, etc., so the above
number would be increased consequently with the number of
other vertebrate species (for the moment viruses of invertebrates,
a world largely to be discovered, will not be considered). Like-
wise, let’s bear in mind that there are other taxonomic families
of viruses besides the Herpesviridae family, like the Poxviridae
(e.g., smallpox and myxomatosis), Flaviviridae (e.g., yellow fever
and dengue), Orthomyxoviridae (e.g., inﬂuenza), Picornaviridae
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(e.g., foot-and-mouth disease, polio, and hepatitis A), Reoviridae
(e.g., BT and African horse sickness), etc., and for each family
of viruses one can reason about in the same way. In light of this
example, a ﬁrst conclusion is that we only know a fraction of
the viral pathogens that actually exist. To these, we must add
the non-pathogenic viruses that circulate silently, which obvi-
ously are less known, and which probably exist in far greater
numbers and variety than their pathogenic counterparts. The
complexity of viruses of plants, bacteria, fungi, and parasites is
not lower than that of animal viruses. This gives a rough idea of
the real complexity of the virus world in which only a small part
is known.
THE GENESIS OF INFECTIOUS DISEASES
Despite the distress and alarm that the emergence of a new infec-
tious disease causes, the fact is that organisms change over time in
adaptive processes that determine their evolution, and this implies
the emergence of new infectious diseases and the disappearance
or change of the existing ones. These processes are therefore nor-
mal and expected to occur with some frequency, as a result of the
high generation rates and enormous capacity for mutation and
adaptation exhibited by microorganisms in general, and viruses in
particular.
The term emerging infectious diseases applies to those diseases
in which any of the following situations is applicable: (1) a known
infection spreading to a new geographic area or population, (2) a
new infection that occurs as a result of evolution or change of
an existing pathogen, and (3) a previously unknown disease or
pathogen that is ﬁrst diagnosed (Brown, 2004; OIE, 2011). Factors
determining the emergence of an infectious disease are largely
unknown, although they are related to the adaptation of infectious
agents to new species (Lederberg, 1997) and/or to the concomi-
tant appearance of changes in the environment that offer new
opportunities for pathogens to thrive (Smolinski et al., 2003).With
regard to adaptation to new species, ﬁrst it is worth reminding
that every virus has its own “host range,” that is, the variety of
species susceptible to be infected by a particular virus. There are,
on one hand, viruses with a broad range of hosts, for example,
West Nile virus (WNV), that is capable of infecting hundreds of
species of birds, as well as many species of mammals, reptiles,
and amphibians (McLean et al., 2002), and, on the other hand,
viruses with a narrower range of hosts such as, for instance, clas-
sical swine fever virus, which only infects suidae (pigs and wild
boar; OIE, 2008), or the aforementioned herpesviruses, each of
which usually infect speciﬁcally one or a few related species (Pellet
and Roizman, 2007).
Two cases can be distinguished with regard to pathogen adap-
tation to new host species: in the ﬁrst, the pathogen completes
its cycle and survives normally in a given species which acts as
reservoir host, but occasionally infects other(s), causing disease
in these “incidental hosts.” This occurs in a number of zoonoses.
A good example is given by highly pathogenic avian inﬂuenza
virus subtype H5N1 of Asian origin (H5N1 HPAIV), now present
on three continents. Different wild birds act as reservoir hosts
for this virus, which affects severely different species of domestic
poultry, causing enormous losses to the poultry industry (Alexan-
der, 2000). However, besides birds, it occasionally affects some
species of mammals, including humans (causing a zoonosis), cats,
and mustelids like ferrets and martens, in which it is extremely
pathogenic. Nevertheless, transmission of H5N1 HPAIV between
individuals in mammal species is not effective at all (Imai and
Kawaoka, 2012), a fact that luckily prevents by now a possible pan-
demic of disastrous consequences for humankind. In the second
case, the adaptation to new species is more “genuine” in the sense
that the pathogen has indeed crossed the “species barrier,” that is,
has established a complete cycle of transmission in a new species.
It can be assumed that all viruses currently known went through a
process like this in their past evolution to adapt to the specieswhich
are their current natural hosts. Inﬂuenza viruses themselves were
adapted to their avian hosts in remote times. Some of them gave
rise, through analogous adaptation processes, to the current swine,
equine, and human inﬂuenza viruses, which are able to complete
an infectious cycle in these species, independently of birds (Suarez,
2000). Among the viruses that have undergone a process of adap-
tation to a new species, it is worth reminding the case of swine
vesicular disease virus, which causes an economically important
disease inpigs (Escribano-Romero et al.,2000). This virus is closely
related genetically to Coxsackie virus B5, a human enterovirus,
and current evidence suggests that it arose as a result of a relatively
recent adaptation from human to swine (Jimenez-Clavero et al.,
2005a), providing a good example that adaptations and crossing
the species barrier can go either to or from humans, and that the
human being is just one more species in this regard. Other viruses
that have recently emerged to affect new species are several variants
of the genus Henipavirus, infecting bats in Southeast Asia (Nipah
virus) and Oceania (Hendra virus; Eaton et al., 2006). In recent
years an increase in fatal cases by these viruses in humans and
livestock (pigs and horses) has been observed, but an inefﬁcient
transmission between individuals of these species has prevented
further spread in the human and/or livestock populations. How-
ever, in a recent outbreak of Nipah virus occurring in Bangladesh it
appeared that an efﬁcient transmission occurred between humans
(Gurley et al., 2007). Finally, it is important to note that there is
probably a species barrier crossing after every ﬁrst diagnosis of a
viral emerging disease, even though the natural reservoir might
remain unknown. In 2003, the ﬁrst cases of what appeared to be
a new disease entity with fatal consequences for affected humans,
were diagnosed in Hong Kong. It received the name of severe
acute respiratory syndrome (SARS) and caused a great social con-
cern worldwide, particularly when clusters of cases were detected
in up to a dozen countries in three continents around the world,
although a rapid response prevented further spread. The causative
agent of this disease, named SARS virus, was identiﬁed during
earlier investigations (Drosten et al., 2003; Kuiken et al., 2003), but
its natural host remained unknown until Rhinolophidae (horse-
shoe bats) species were identiﬁed as reservoir hosts (Li et al., 2005;
Cui et al., 2007).
INFLUENCE OF THE ENVIRONMENT IN INFECTIOUS DISEASES
The environment of viruses is constituted essentially by the cells
they infect. Viruses must parasitize cells to ensure their propa-
gation. Outside cells, viruses lack of activity, although to allow
transmission to another individual they need to survive outside
the cell. The way a virus survives in the environment is the result
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of an adaptation that largely determines how it is transmitted.
Viruses can be transmitted through direct contact between indi-
viduals, or through other ways such as, for instance air, water,
feces, body ﬂuids, food, or fomites. In some cases, transmis-
sion needs the participation of other living organisms, so-called
vectors, in which the virus is equally propagated. These vec-
tors are often blood-sucking insects that inoculate the infectious
pathogen through their bites, thus spreading the infection in a
population. A virus may preferably use a single transmission
route, but viruses using more than one way of transmission are
frequent.
The progress of a viral infection in a population is a multifac-
torial process, depending on a range of both biotic and abiotic
factors. These factors and their inﬂuence on the development
and transmission of the infection at the population level con-
stitute the eco-epidemiology of an infectious disease. There is a
strong relationship between the route of transmission and the eco-
epidemiology of a given infectious disease. For example, the spread
of infections that are transmitted by direct contact largely depends
on the population density, which determines the distance between
infected and susceptible individuals. For airborne infections, tem-
perature, humidity, and wind can have a signiﬁcant inﬂuence on
the progress of the epidemic. Waterborne and foodborne viruses
are usually highly resistant to adverse environmental conditions.
A particular case of this type of transmission is represented by
the fecal–oral route (often water, food, or objects are contami-
nated by fecal waste). Viruses that are transmitted through this
route have a characteristic resistance to low pH, allowing them
to pass through the animal’s digestive tract, overcoming the nat-
ural barrier that represents the acid secretion of gastric parietal
cells. Often, these viruses produce diarrhea, thus being shed in
large amounts and returning to the environment, where they can
remain infectious for a variable period (up to several months in
some instances), depending mainly on environmental tempera-
ture (the colder the longer), but also on the presence of salts,
organic matter, moisture, solar radiation, etc., until they reach
another host andbegin the infectious cycle again (Jimenez-Clavero
et al., 2005b).
In the case of vector-borne diseases, in addition to pathogen
and host, infectious cycle requires a third player: the vector. This
fact results in a more complex eco-epidemiology. Habitats of
arthropod vectors depend on a number of environmental condi-
tions, including range of temperature, humidity, water availability,
etc. Arboviruses (i.e., viruses transmitted by arthropod vectors),
are distributed necessarily in areas where populations of compe-
tent vectors (i.e., vectors which are able to spread the disease to
new hosts) are abundant enough. Each arthropod vector species
occupies a particular ecological niche within speciﬁc environmen-
tal conditions, so that its distribution can be greatly affected by
changes in temperature, rainfall, humidity, plant coverage, etc.
(Randolph and Rogers, 2010; Weaver and Reisen, 2010).
In summary, environmental variations constitute an important
factor in the occurrence and spread of infectious diseases in gen-
eral. This is particularly important for arthropod-borne diseases,
where environmental changes can inﬂuence both their geographic
range and the risk of introduction (Sutherst, 2004; Gould and
Higgs, 2009; Tabachnick, 2010).
EMERGING INFECTIOUS DISEASES AND GLOBAL CHANGE
The Planet Earth is in continuous change. Environmental changes
are driven by both abiotic and biotic factors. Of these, impact
caused by humans has gained importance as the human popula-
tion has risen, from the local level to reach a global scale (Meadows
et al., 1972). Global change is deﬁned as the impact of human
activity on the fundamental mechanisms operating in the bio-
sphere (Duarte, 2006). Global change comprises not only impacts
on climate, but also on the water cycle, land use, biodiversity loss,
invasion of alien species into new territories, introduction of new
chemicals in Nature, etc. The inﬂuence of global change on emerg-
ing infectious diseases has been the subject of different revisions
(Fayer, 2000; Weiss and McMichael, 2004; Wilcox and Gubler,
2005; Patz et al., 2008). As noted above, environmental changes
largely determine the evolution of many emerging infectious dis-
eases,most notably arthropod-borneones (see reviewsby Sutherst,
2004; Gould and Higgs, 2009; Tabachnick, 2010), Therefore, cli-
mate changes will impact necessarily on these diseases (Rosenthal,
2009). However, there are many other driving factors – not only
those related to climate changes – that have or have had a pow-
erful inﬂuence on the occurrence or change of many infectious
diseases. Table 1 shows some of these drivers, identiﬁed as rele-
vant in the emergence and re-emergence of infectious diseases in
a recent study (Woolhouse and Gowtage-Sequeria, 2005). It is not
the purpose of this article to review systematically all these fac-
tors, which have been reviewed elsewhere (Smolinski et al., 2003;
Woolhouse and Gowtage-Sequeria, 2005) but to brieﬂy expose
some examples, in order to highlight their relative importance
in the emergence of infectious diseases in an overall context of
globalization.
For instance, intercontinental transport by air makes it possible
to move persons and goods thousands of miles away within few
hours. For a person who has just acquired an infection it is pos-
sible to arrive to destination even within the incubation period,
Table 1 | Main categories of factors associated to the emergence and
re-emergence of human pathogens. Seventy-ﬁve percent of them are
zoonotic (from Woolhouse and Gowtage-Sequeria, 2005).
Rank* Driver
1 Changes in land use or agricultural practices
2 Changes in human demographics and society
3 Poor population health (e.g., HIV, malnutrition)
4 Hospitals and medical procedures
5 Pathogen evolution (e.g., antimicrobial drug resistance, increased
virulence)
6 Contamination of food sources or water supplies
7 International travel
8 Failure of public health programs
9 International trade
10 Climate change
*Ranked by the number of pathogen species associated with them (most to
least).
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and develop (and transmit) the disease upon arrival, resulting
in an “imported disease.” This not only applies to people, but
occurs similarly as a result of trade of live animals and their
products, an important economic activity worldwide, which is
subjected to strict regulations (OIE, 2011) that must be imple-
mented in coordination with all countries, precisely to prevent
the spread of infectious diseases harmful to livestock, which in
this context are called “exotic” or “transboundary” diseases. How-
ever, these rules have been insufﬁcient to halt the spread of many
infectious animal diseases of tremendous economic impact, partly
because control and surveillance systems do not always work effec-
tively. As an example of what an effective control can achieve, it is
worth to mention what constituted the ﬁrst detection in Europe
of highly pathogenic avian inﬂuenza virus H5N1 fromAsia, which
occurred in 2004 at a border checkpoint in the airport of Brussels
(Belgium). Customs ofﬁcers detected in the luggage of a traveler
from Thailand two mountain hawk eagles (Spizaetus nipalensis)
alive, apparently brought as a gift. The two birds were found
to be infected with the virus (Van Borm et al., 2005). This case
also reminds that, in addition to the above, illegal trafﬁcking of
animals, including exotic species, must also be considered as a rel-
evant factor involved in importation of transboundary diseases.
A good example was given in 2003 by the occurrence of outbreaks
of monkeypox in humans in the U.S., originated as a result of
illegal import of infected exotic rodents from Ghana (Guarner
et al., 2004). The disease has reached local populations of rodents
(prairie dogs, Cynomys spp.).
Regarding arboviral diseases, the impact of trade and transport
on the distribution of vectors is reﬂected by the global expansion
of the tiger mosquito (Aedes albopictus), associated with trade
in used tires (Reiter and Sprenger, 1987) or in Dracaena plants
(“lucky bamboo”; Madon et al., 2002). Rain causes small pools of
water inside the tires stored outdoors. This constitutes an excellent
breeding habitat for this mosquito, because it mimics the hollow
trunks of rainforest trees that are its natural habitat. Through
transport of used tires containing A. albopictus eggs, this mosquito
has reached a worldwide distribution. This mosquito is a compe-
tent vector of many pathogens, including dengue, yellow fever,
chikungunya, Venezuelan equine encephalitis, and WNF (Paupy
et al., 2009; Weaver and Reisen, 2010).
Other factors derived from human activities linked to the
emergence of infectious diseases are those related to land use: a
growing human population is demanding more resources neces-
sary for its supply and welfare, particularly food, but also energy,
raw materials, water, urban land, etc. New agricultural planta-
tions and livestock grazing plots on deforested lands promote
the emergence and/or spread of infectious diseases hitherto con-
ﬁned to the forest habitat (Smolinski et al., 2003; Woolhouse and
Gowtage-Sequeria, 2005).
Deforestation and biodiversity loss are often cited as causes
of increased incidence of emerging infections in certain regions.
An example can be found in the emergence of Junin virus in
Argentina (Charrel and de Lamballerie, 2003). Changes in water
use are, nonetheless, one of the factors most clearly related to
the modiﬁcation of eco-epidemiological patterns accompanying
emerging infectious diseases. New irrigation plans, construction
of dams, etc. have a direct effect on the abundance of competent
vectors for transmission of various arboviruses. The new irriga-
tion in northwestern Australia seem to be the main cause of the
recent expansion of Murray Valley fever, an emerging zoonotic
arbovirus in that country (Mackenzie et al., 2004). The con-
struction of dams may have caused an important impact on the
recent emergence of Rift Valley fever in East Africa, causing highly
virulent outbreaks for both man and livestock, by allowing a dra-
matic increase in mosquito populations involved in transmission
(Martin et al., 2008).
Healthcare is another area of human activity that, somehow
paradoxically, is linked in many instances to infectious disease
emergence. Iatrogenic transmission of infectious diseases, through
transfusions, transplants, and other medical interventions, has
undoubtedly had an effect on the expansion of certain pathogens
such as hepatitisC virus (Alter,2002; Prati,2006). Fortunately, cur-
rent medical practice has reduced this risk very signiﬁcantly (Alter,
2002; Prati, 2006). The administration of biologicals derived from
animals or animal cell cultures, such as vaccines and therapeu-
tic products, can also act as a vehicle for the transmission of
pathogens (Parkman, 1996). Despite strict controls on each batch
of vaccine for the presence of certain pathogens, there have been
cases of transmission of adventitious viruses in contaminated vac-
cines. One of the best known cases of this kind is represented
by bovine viral diarrhea virus (BVDV), a pestivirus affecting cat-
tle. In the manufacturing process of many vaccines, cell cultures
are widely employed, and fetal calf serum is used as an addi-
tive common to cell culture media. BVDV is highly prevalent
in cattle and certain variants of the virus remain unnoticed in
cell cultures. In some cases, batches of fetal calf serum from
BVDV-infected animals were used inadvertently, resulting in viral
contamination of vaccines. Some of them (those addressed to the
bovine, such as vaccine against bovine herpesvirus type 1) even-
tually resulted in outbreaks of viral diarrhea in vaccinated cattle,
which alerted for the presence of the virus (Makoschey et al., 2003).
Currently, regulatory agencies, such as the European Medicines
Agency, have modiﬁed their safety requirements to control specif-
ically the risk of contamination by animal pestiviruses in drugs
and vaccines.
CLIMATE CHANGE AND EMERGING INFECTIOUS DISEASES
Global warming is the rise in average surface temperature of the
earth observed in the last decades (+0.6◦C in the last half cen-
tury; IPPC, 2007). This observation applies also speciﬁcally to
Europe (EEA, 2012) and North America (Karoly et al., 2003),
territories particularly concerned to WNV and BT virus (BTV)
emergences, as it will be discussed later. The increase has accel-
erated in recent years and is expected to go faster, so that in the
twenty-ﬁrst century the average surface temperature of the earth
is expected to rise in a range between +1.6 and +6◦C, depend-
ing on the different scenarios considered (IPPC, 2007). Although
still a contentious issue, most scientists now accept that human
activity has contributed to the observed global warming (Oreskes,
2004), mostly through emissions of greenhouse gases produced
by industrial activity and consumption of fossil fuels for trans-
port, energy production, etc. (IPPC, 2007). The impact of global
warming on the environment is the subject of numerous recent
studies, based on predictive modeling scenarios depending on the
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level of emissions. It is not the purpose of this article to review
these models, which are described extensively elsewhere (IPPC,
2001, 2007), but to highlight some future climate trends,mainly in
Europe, the scenario for some recent unusual observations regard-
ing arboviral diseases (Purse et al., 2008; Wilson and Mellor, 2009;
Zientara et al., 2009; Calistri et al., 2010; MacLachlan and Guthrie,
2010; Sotelo et al., 2011a). For this, I will rely on data from the
European project PRUDENCE (Prediction of Regional scenarios
and Uncertainties for Deﬁning EuropeaN Climate change risks
and Effects; Christensen, 2005). Table 2 summarizes the most
marked trends for Europe in the next 100 years according to
this study. In addition to an increase in mean annual air tem-
perature, predicted to be between 1.4 and 4.5◦C, depending on
the areas (the highest rise is expected to occur in the Iberian
Peninsula), the study suggests there will be more droughts, more
wildﬁres, heat waves will be more frequent, and all this will be
particularly noticeable in southern Europe. Winters will become
milder, and this will occur more rapidly in northern latitudes.
As a result, frost will decrease, and minimum temperatures will
rise. These circumstances favor living cycles of certain arthro-
pod vectors, which in these conditions will be able to overwinter
more easily in latitudes and areas beyond their current geographic
ranges. Other remarkable trends include rising temperatures and
unusually hot summers, but also greater interannual variabil-
ity, particularly in central Europe, which will make adaptations
more difﬁcult. Waves of extreme temperatures (both cold and
heat) will become more frequent. With regard to rainfall, the
Table 2 | Long-term climatic trends in Europe, based on data from
PRUDENCE* (Prediction of Regional scenarios and Uncertainties
for Defining EuropeaN Climate change risks and Effects;
Christensen, 2005).
Parameter Trend
Air temperature Rise in air temperature
Winter temperature Milder winters
Seasonal variation Less seasonal variation
Drought stress Higher drought stress
Forest ﬁres More forest ﬁres
Night-time temperatures (frost) Warmer night-time temperatures
Heat waves More days of extreme heat and heat
waves in summer, and more year-to-year
variability
Very hot summers Unusually hot summers more frequent
Rainfall Rainfall: increase in the North and
decline in the South
Snow Snow: decline
Floods Floods: more frequent
Strong winds Higher frequency of hurricanes/cyclones
(hurricanes/cyclones) with extreme strength
*PRUDENCE was a project funded by the European Commission under its ﬁfth
framework programme. It had 21 participating institutions from a total of 9 Euro-
pean countries. For further information, see PRUDENCE: http://prudence.dmi.dk/
tendency is to increase in northern Europe and decrease in the
South. Therefore, increasingly severe droughts are expected in
southern Europe, with a considerable impact on agriculture and
water resources. However, torrential rains, especially in summer,
will become more common throughout Europe, causing ﬂooding
to occur more frequently. Snow will become rarer. River ﬂows
will decrease in the South, and increase in northern Europe.
Extreme wind events (hurricanes, cyclones) will also be more
frequent.
How will these climate changes impact on emerging infectious
diseases? The consequences of global warming are expected to
be diverse and highly variable in different geographical locations.
For example, as noted above, the effects of climate change in
Europe will differ signiﬁcantly between northern and southern
latitudes, and these differences could even be greater at the local
level, although they will not be easily distinguished from weather
variations. These changes may affect disease emergence not only
through direct effects on populations of vectors, reservoirs, and
hosts, but also indirectly, through, for instance, induced changes
in human activities. For instance, in a scenario like that depicted
in the predictive climatic models above cited for southern Europe,
lower rainfall, increased temperature, and reduced water avail-
ability will have important consequences not only on agricultural
activities which, as already noted, have a major impact on infec-
tious diseases, but for example on tourism, which is the main
source of wealth in these regions. A signiﬁcant decline in economic
activity could lead to a decrease in population, food demand, and
hence livestock. In this changing context, plenty of uncertainties, it
is difﬁcult to predict an overall trend: some infectious diseases will
probably emerge, some existing ones will spread, and others may
disappear. Even in speciﬁc cases a disease may be exacerbated tran-
siently and disappear later. For example, the cease of agricultural
production in irrigation areas, which can likely occur in a scenario
of extreme drought, could lead at long-term to local extinction
of mosquito-borne diseases, whose breeding habitat depends on
the infrastructure dedicated to this type of agriculture. However,
disuse and neglect could favor the accumulation of organic mat-
ter in certain points of these infrastructures, turning them into
optimal habitats for breeding of vectors, something that the nor-
mal maintenance of the network usually avoids. This would likely
lead to a transient increase in the incidence of certain diseases,
although prolonged drought would eventually lead these vectors
to extinction.
The effects of climate change are beginning to be perceived,
and at the same time remarkable changes in the geographic range
and incidence of some infectious diseases are being observed,
suggesting some kind of relationship, which is difﬁcult to ascer-
tain. As remarked above, climate change is not the only factor
inﬂuencing infectious disease emergence, as there are other com-
ponents in the global change which have also important effects
on disease emergence. The following sections deal with two of the
emerging arboviral diseases of animals that have changed more
radically their epidemiological patterns in recent years: BT and
WNF (Zientara et al., 2009). Climate, weather and other factors
related to global change which are potentially involved in dis-
ease emergence will be examined speciﬁcally for each of these two
diseases.
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BLUETONGUE
THE VIRUS AND THE DISEASE
Bluetongue is a non-contagious infectious disease of rumi-
nants (reviewed in MacLachlan, 1994; Wilson and Mellor, 2009;
MacLachlan, 2011). Mainly affects sheep, particularly some
selected European breeds. Cattle and goats act as reservoirs of
the virus, which infect these animals usually producing a milder
disease, often asymptomatic. The disease can affect alsowild rumi-
nants, severely in some species. BT is an economically important
disease for livestock, included in the list of notiﬁable diseases to
the OIE (World Organization for Animal Health) and is therefore
subject to strict regulations regarding the trade of animals and
their products (OIE, 2011), causing severe economic losses in the
affected countries.
Clinical manifestations range from subclinical infection to
acute illness that can be fatal. Expression of BT disease reﬂects
a variety of virus, host, and vector factors (MacLachlan, 2004).
Clinical signs in sheep include pyrexia, tachypnea, nasal discharge,
and lethargy. Pathology is characterized by generalized edema,
hemorrhage, especially in lymph nodes, lungs, heart, and skeletal
muscle and necrosis on the surface of the oro-nasal mucosa and
gastro-intestinal tract (reviewed in MacLachlan et al., 2009).
The causative agent, BTV, belongs to the family Reoviri-
dae, genus Orbivirus, has a genome of segmented double-
stranded RNA (dsRNA), contained in a non-enveloped capsid
shell (reviewed in Schwartz-Cornil et al., 2008). Its main route
of transmission is through the bite of midges of the genus Culi-
coides. The BTV genome is divided into 10 dsRNA segments which
encode seven structural (VP1–VP7) and four non-structural
(NS1, NS2, NS3, and NS3a) proteins. BTV is closely related to
other orbiviruses such as African horse sickness virus (AHSV)
and epizootic hemorrhagic disease of deer virus (EHDV), to
which it shares not only physico-chemical characteristics but also
eco-epidemiology and vector type, although differing in host
range. As for now, 26 serotypes of BTV have been described
(two of them very recently; Hofmann et al., 2008; Maan et al.,
2011), with no cross-protective immunity between them. Within
each serotype there is also a great variability, largely facili-
tated by the segmented genome, allowing genetic “reassortment.”
This enables these viruses to generate multiple variants that
may differ in important characteristics or phenotypes, such as
pathogenesis, host range, vector competence, or transmissibility
(MacLachlan, 2004).
Viremia is transient, starting at 3–5 days after infection in
sheep somewhat later in other ruminants, peaking at about 7–10
days, declining slowly thereafter (Darpel et al., 2007). The dura-
tion of viremia is variable, depending on the species affected,
and can last for 5–6 weeks in sheep, up to 8 weeks in cattle
(MacLachlan et al., 1994; Bonneau et al., 2002). Virus detection
in blood is commonly used as a proof of infection in diagnostic
tests based in speciﬁc reverse transcription-polymerase chain reac-
tion (RT-PCR) methods (Jimenez-Clavero et al., 2006). The host’s
immune system responds to infection by generating serotype-
speciﬁc neutralizing antibodies, which are widely recognized as
key factors in the long-term protective response against infection
(Schwartz-Cornil et al., 2008). Seroconversion occurs between 1
and 2 weeks after infection. Serogroup-speciﬁc antibodies are
directed primarily to theVP7 protein of the virus capsid, which are
commonly detected by enzyme immunoassay (ELISA) employ-
ing recombinant VP7 antigen (Afshar et al., 1992; Mecham and
Wilson, 2004), while serotype-speciﬁc neutralizing antibodies
(which are detected by speciﬁc neutralization tests) recognize epi-
topes in the VP2 capsid protein (DeMaula et al., 1993; Pierce et al.,
1995). The presence of speciﬁc antibodies in serum samples is
another common diagnostic test, which indicates that infection
has occurred, or that the animal has been vaccinated. There are
live attenuated and inactivated vaccines, which are speciﬁc for each
serotype.
BLUETONGUE ECO-EPIDEMIOLOGY
Survival and transmission of BT in an area requires the pres-
ence of Culicoides vectors. To be transmitted, BTV must infect
a competent Culicoides vector. In this process the vector acquires
the infection by feeding on blood from a viremic host, then the
virus multiplies and disseminates throughout the vector body,
reaching the salivary glands, ready to be inoculated in the next
host after biting on a further blood feed. There is no transo-
varial transmission of the virus. There are approximately 1,500
known species of Culicoides midges, of which about 50 have been
shown to be competent for BTV transmission (Wilson and Mel-
lor, 2009). In different endemic areas, BTV is transmitted through
one or a few distinct local Culicoides species. For example, in
North America this species is Culicoides sonorensis, while in south-
ern Europe and Africa Culicoides imicola is the dominant vector.
The distribution and abundance of Culicoides species involved in
BTV transmission matches with the distribution of the disease
in endemic areas (Mellor and Wittmann, 2002). It also depicts
the maps of areas at risk for its introduction. Similarly, season-
ality strongly inﬂuences vector populations throughout the year,
and this determines the periods of occurrence of disease cases
(Mellor and Wittmann, 2002). For instance, in temperate zones of
the northern Hemisphere most cases of disease occur between
August and November, coinciding with the period of greatest
abundance of vectors. Among the key factors linking weather to
BTV epidemiology, temperature has a crucial inﬂuence on vector
survival, which, as noted above, directly affects disease occurrence,
transmission, and spread. For example, the mean survival time of
a Culicoides midge depends on the temperature, i.e., survive longer
at lower temperatures (Veronesi et al., 2009). By contrast, higher
temperatures promote breeding and feeding of the vectors, which
increases virogenesis and transmission of BTV (Wilson and Mel-
lor, 2009). The optimal range of temperature lies between 13 and
35◦C. However, excessively high (above 40◦C) or low (<0◦C) tem-
peratures are lethal in a short period of time. Between 0 and 13◦C
Culicoides midges remain in a state of dormancy that allows them
to survive until more favorable temperatures allow resuming their
activity. Relative humidity is also a key factor in Culicoides life
cycle (Wittmann et al., 2002). The mentioned temperature ranges
are valid only above a minimum relative humidity. Winter survival
(overwintering) is crucial for the maintenance and consolidation
of the presence of BTV in a geographic area. Midge survival is
favored by mild, frost-free, winters. Wind is another important
factor that links weather to BTV eco-epidemiology. Wind blows
can drag swarms of Culicoides midges, and bring them hundreds
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of kilometers away. This mechanism has been widely recognized
as an important way Culicoides (and BTV, if present in the vectors)
spread, bridging distances up to 700 km under favorable condi-
tions (Carpenter et al., 2009; MacLachlan and Guthrie, 2010). This
form of dispersal is the most likely way BTV has reached the shores
of southern Europe fromAfrica in many occasions in the last years
(Wilson and Mellor, 2009).
As noted above, though primarily pathogenic in sheep (par-
ticularly in some selected breeds) BTV can infect a variety of
ruminants, where the disease often remains asymptomatic. For
the transmission to occur the virus must replicate in the host to
reach a minimum level of viremia which enables it to be ingested
in sufﬁcient amount in a blood feed of a Culicoides vector to be
able to replicate in it. Camels also seem to act as reservoirs (Batten
et al., 2011), possibly playing a role in the spread of the disease
by facilitating the virus to get through the “sand barrier” repre-
sented by the Sahara desert, which stands between the tropics and
subtropics (where BTV is endemic), and North Africa and Europe
where it causes epizootics periodically. This role for camels not
only for BT, but also for other epizootic arboviral diseases is sup-
ported by recent serological evidence (El-Harrak et al., 2011; Touil
et al., 2012). South American camelids are susceptible to the infec-
tion, but develop only a mild form of the disease (Schulz et al.,
2012). A wide range of wild ruminant species are susceptible to
BTV infection, but only a few suffer from severe disease, including
white-tailed deer (Falconi et al., 2011) and mouﬂon (Fernandez-
Pacheco et al., 2008; Lopez-Olvera et al., 2010). The role of wild
ruminants in the eco-epidemiology of BTV is less known.
BLUETONGUE: PAST AND PRESENT
Bluetongue was ﬁrst described in South Africa in the eigh-
teenth century, affecting importedmerino sheep (MacLachlan and
Guthrie, 2010). Outside Africa, BTV was detected for the ﬁrst time
in Cyprus in 1943. Shortly after it was found in North America,
Middle East, Australia, and Asia, as an endemic disease affecting
tropical and subtropical areas with epizootic incursions in tem-
perate zones where the presence of competent vectors allowed its
transmission (MacLachlan, 2004). Traditionally, its natural geo-
graphic range was considered to be located between latitudes 35◦S
and 40◦N. In Europe, regions with suitable conditions for incur-
sions of BT were the south of the Iberian and Italian Peninsulas
and some islands of the Aegean Sea, where climate and presence
of competent vectors, along with the proximity to endemic areas
(Middle East and Africa) contributed to create an area at high risk
of entry of the disease (reviewed in Mellor and Wittmann, 2002;
Mellor et al., 2008). In 1956, BT burst into the Iberian Peninsula
from Africa, causing major losses in sheep. However, apart from
this episode and some subsequent incursions in Cyprus and the
Greek islands of Lesbos and Rhodes, Europe had remained free
of this disease, which was considered “exotic” in this continent.
This situation began changing after 1998, with increasingly fre-
quent outbreaks in the Mediterranean islands and in southern
continental Europe (Mellor and Wittmann, 2002; Mellor et al.,
2008). A parallel upsurge was observed meanwhile in the Middle
East and the North of Africa. Between 1998 and 2001, BT out-
breaks were declared in the territories of Greece, Bulgaria, Turkey,
Macedonia, Serbia, Croatia, Montenegro, Bosnia-Herzegovina,
Albania, Italy, France, and Spain. BTVs involved belonged to at
least ﬁve different serotypes (1, 2, 4, 9, and 16). Four of them
(1, 2, 9, and 16) came from the East (Middle East), and two
more introductions from the South (Africa) involved serotypes
2 and 4 (Mellor et al., 2008). Even during this period the disease
showed some expansion to the North, breaking the northern limit
of the disease in Europe, represented by latitude 40◦N, with some
outbreaks occurring near 45◦N in the Balkans. Since then, BT is
considered an emerging disease in Europe (Wilson and Mellor,
2009). But the quantum leap in the epidemiology of the disease
in Europe was to take place in August 2006 when an outbreak
of BT was declared in the Netherlands at the Maastricht region.
The virus isolated in this outbreak belonged to serotype 8, and
was the ﬁrst occurrence of this serotype in Europe (Wilson and
Mellor, 2009). The disease has since spread with unprecedented
speed and virulence, affecting ﬁrst Holland, Belgium, Luxem-
bourg, France, and Germany, and expanding rapidly into the UK,
Austria, Czech Republic, Switzerland, Denmark, Italy, and Spain
(Saegerman et al., 2008). Since then the virus showed its ability
to overwinter in unusually high latitudes, remaining present in
most of Europe, and even spreading to other European countries
such as Hungary, Norway, and Sweden. The number of outbreaks
produced by this BTV8 in Europe since its ﬁrst detection in 2006
is 89,136 (EUBTNET, 2011). The incidence of the disease peaked
in 2007 with 50,479 outbreaks declared. Massive vaccination cam-
paigns, initiated in 2008, contributed largely to control the disease,
so that the number of outbreaks were drastically reduced since
2009, and practically disappeared in 2010 and 2011 (EUBTNET,
2011). The epidemic of BTV8 in Europe was unusual not only
because of the latitude in which it occurred, immediately sug-
gesting that vectors involved in transmission should be different
from those “expected” and more common in southern Europe
(C. imicola). In fact, it appears that the BTV8 responsible for the
epidemic was adapted to midge species more common in north-
ern Europe, such as those of the C. obsoletus complex (Wilson and
Mellor, 2008). Another remarkable characteristic of this virus is
its special virulence and pathogenicity, which also affected cattle.
In addition, this virus seems able to be transmitted to the fetus
through the placenta, a feature that had only been observed in
infections with attenuated BTV vaccine strains, and never in BTV
ﬁeld strains (MacLachlan et al., 2009). These unusual character-
istics illustrate perfectly the principle of emerging viruses arising
from an underlying pool of varying viruses, with new properties
that may result in new ecological and epidemiological patterns of a
viral disease.
But recent occurrence of BT in Europe has not been limited to
the, otherwise outstanding, BTV8 epizootic. Other serotypes have
reached the shores of the southern European countries and caused
severe harm to livestock in these years (Mellor and Wittmann,
2002; Saegerman et al., 2008). Of particular relevance were the
incursions of BTV serotype 4 in Spain, Italy, and the western
Mediterranean islands in 2003–2004, and the entry of a partic-
ularly highly pathogenic strain of BTV serotype 1 ﬁrst in Sardinia
(Italy) in 2006, and then in Spain in 2007, which extended rapidly
to Portugal and France, causing also many thousands of outbreaks
in these countries. The same strategy adopted to ﬁght against
the BTV8 epizootic, based on vaccination campaigns, was used
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simultaneously against BTV1 and BTV4, with the same success at
reducing disease incidence to almost negligible (Wilson and Mel-
lor, 2009). Currently, new incursions of different BTVs continue
threatening Europe, a continent that will no longer be considered
out of reach of BT.
BLUETONGUE: FUTURE TRENDS
In the past 15 years very signiﬁcant qualitative changes have
occurredwith regard to the epidemiology of BT,which has reached
unprecedented severity in Europe (Wilson and Mellor, 2008, 2009;
Zientara et al., 2009). Some important trends observed in this
period are: (1) a major increase in the frequency of BTV incur-
sion events in Europe, (2) a geographic expansion of the disease,
reaching latitudes close to parallel 55◦N, i.e., 15◦ beyond the clas-
sic northern distribution limit for BT in Europe, (3) an ability
to overwinter in locations a priori unsuitable for known com-
petent vectors, (4) changes in some strains with regard to their
pathogenicity (BTV1 strain is highly pathogenic in sheep; unpub-
lished observation) and host range (BTV8 strain is pathogenic
in European bovine), and (5) new ways of transmission (BTV8
strain can be transmitted transplacentally, affecting fetuses and
newborn cattle).
What is the explanation for all these changes? Undoubtedly,
the rising temperature in Europe in recent years (EEA, 2012)
is a factor having a major inﬂuence in this situation (Purse
et al., 2008; Wilson and Mellor, 2008). Particularly, unusually
mild winters that occurred in 2006–2007 and 2007–2008 in the
affected areas have probably favored the habitat of certain Culi-
coides species that could act as vectors in these regions, promoting
their geographical expansion. Some studies indicate that the dis-
tribution of C. imicola, the principal vector of BTV in southern
Europe, has undergone a geographic expansion, reaching areas
where it had never been observed, for example the North of
Spain (Goldarazena et al., 2008), although some authors have
not observed expansions of this vector in Italy in recent years
(Conte et al., 2009). Nevertheless, in northern and central Europe,
competent vector species must be different, because C. imicola
is not present in these areas (Saegerman et al., 2008). Other
likely competent vectors for BT which are present in Europe are
C. obsoletus, C. pulicaris, C. scoticus, and C. dewulﬁi (Saegerman
et al., 2008). For some of these vector species, their vectorial
capacity for BT transmission was considered secondary or even
irrelevant, as compared to C. imicola. However, changes in circu-
lating viruses involving adaptations to some of these vectors may
have improved this capability. On the other hand, it is a well-
known fact that the temperature can affect vector competence,
effectively increasing it above a certain temperature threshold
(Wilson and Mellor, 2009).
But climate change alone is insufﬁcient to explain the whole
picture regarding the current rise of BT in Europe. First, I have
already mentioned how the wind can drag swarms of infected
Culicoides, spreading thedisease to considerable distances, and that
this is likely route of entry of BT in southern Europe (Ducheyne
et al., 2007), though animal movements could also play a role.
I have also mentioned how camels could act as carriers for these
viruses from sub-SaharanAfrica toNorthAfrica, where BT is often
detected some time before affecting Europe (Touil et al., 2012). But
how was BTV8 introduced into northern Europe? Unlike other
strains that have invaded Europe in recent years, this BTV-8 strain
has not previously been detected in the North of Africa or the
Middle East. Among the few sequence data available to date on
relevant BTV strains, it has been shown that the most similar
virus found is a strain from sub-Saharan Africa (Nigeria) isolated
in 1982 (Maan et al., 2008). This “gap” in space and time indi-
cates clearly that more sequence data from relevant BTV sources
are needed to draw any conclusion about the origin of the Euro-
pean BTV-8 strain. As already discussed in the previous section,
the trade of animals and animal products, as well as of wildlife
(either legal or illegal), may be behind many accidental introduc-
tions of infectious diseases, and this hypothesis should be taken
into account in this case, although thus far, no evidence has been
obtained neither for nor against it (Mintiens et al., 2008). Other
questions remaining where climate change does not provide a full
explanation are (1) the virus ability to overwinter in extremely
cold conditions such as those found in certain areas of northern
Europe, (2) the role that vertical transmission may have on its sur-
vival, and (3) phenotypic changes perceived in some recent BTV
variants, which are more pathogenic and/or affect other species
such as cattle. More research is needed to ﬁnd answers to these
questions.
Bluetongue is no longer a tropical disease, exotic, typical of
warm countries, but it has come to stay in Europe. This radical
change cannot be understood without taking into account global
changes that are taking place in the world of which climate change
plays an important role. Current knowledge indicates that this
climatic change will become increasingly intense in the future,
which, at least in theory, would favor the spread of BT, although
other factors may also modulate this trend.
WEST NILE FEVER/ENCEPHALITIS
THE VIRUS AND THE DISEASE
West Nile virus is the etiological agent of an emerging zoonotic
disease whose impact on animal and public health is considerable,
being the most widespread arbovirus in the world today (reviewed
in Hayes et al., 2005a; Kramer et al., 2008; Brault, 2009). A per-
centage of WNV infections result in severe encephalitis, and it is a
communicable disease both for human and animal health. WNV
taxonomically belongs to the family Flaviviridae, genus Flavivirus.
Virions are spherical in shape, about 50 nm in diameter, and con-
sist of a lipid bilayer that surrounds a nucleocapsid that in turn
encloses the genome, a unique single-stranded RNA molecule,
which encodes a polyprotein that is processed to give the 10 viral
proteins. Of them, three (C, E, and M) form part of the struc-
ture of the virion, and the rest (NS1, NS2a, NS2b, NS3, NS4a,
NS4b, and NS5) are so-called“non-structural”and play important
roles in the intracellular processes of replication, morphogenesis,
and virus assembly. Inserted into the lipid bilayer are two pro-
teins, E (from “envelope”) and M (“matrix”), which participate in
important biological properties of the virus, such as its host range,
tissue tropism, replication, assembly, and stimulation of cellular
and humoral immune responses. E protein contains the major
antigenic determinants of the virus.
As far as we know, there are no serotypes of WNV,but two main
genetic variants or lineages can be distinguished, namely lineages
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1 and 2. While the former is widely distributed in Europe, Africa,
America, Asia, and Oceania, the second is found mostly restricted
toAfrica andMadagascar, although it has recently been introduced
inCentral and Eastern Europe (Bakonyi et al., 2006; Platonov et al.,
2008) and has further extended to southern Europe (Bagnarelli
et al., 2011; Papa et al., 2011). In addition, other viral variants
closely related phylogenetically to WNV have been described,
which are different from lineages 1 and 2, and have been proposed
as additional WNV lineages. One of them, known as “Rabensburg
virus,” isolated form mosquitoes in the Czech Republic in 1997,
shows low pathogenicity in mice (Bakonyi et al., 2005). Similarly,
other viruses closely related to WNV have been isolated in India
(Bondre et al., 2007), Russia (Lvov et al., 2004) Malaysia (Scher-
ret et al., 2001), and Spain (Vazquez et al., 2010). All these viruses
have been proposed to represent different genetic lineages ofWNV.
Except for the Indian variant,whichhas been involved in outbreaks
of encephalitis in humans, the rest are of unknown relevance for
animal and human health.
West Nile fever/encephalitis is a disease transmitted mainly
by mosquitoes, while wild birds are its natural reservoir. WNV
is capable of infecting a wide range of bird species. Neverthe-
less, birds were considered less susceptible to the disease until the
recent epidemic of WNV inNorthAmerica, affectingmany species
of birds lethally, made to re-examine this concept (Komar et al.,
2003). Occasionally it may affect poultry species, mainly geese
and ostriches. Other domestic birds like chickens and pigeons, are
susceptible to infection but do not get sick, and are often used as
sentinels for disease surveillance. In addition to birds, WNV can
also affect a wide range of vertebrates species, including amphib-
ians, reptiles, and mammals, and it is particularly pathogenic in
humans and horses, which act epidemiologically as “dead end
hosts,” that is, they are susceptible to infection but do not transmit
the virus (McLean et al., 2002; Kramer et al., 2008).
The ﬁrst case of WNF was described in Uganda (West Nile dis-
trict, hence thenameof the virus) in a feverishwoman, fromwhose
blood the virus was ﬁrst isolated in 1937 (Smithburn et al., 1940).
It was considered a mild disease, endemic in parts of Africa (an
“African fever”). However, since around 1950s, the occurrence of
disease outbreaks with neurological disease, lethal in some cases,
caused by WNV, especially in the Middle East and North Africa,
made necessary to rethink this concept. In humans, the majority
of WNV infections are asymptomatic, about 20% may develop
mild symptoms such as headache, fever, and muscle pain, and
less than 1% develop more severe disease, characterized by neu-
rological symptoms, including encephalitis, meningitis, ﬂaccid
paralysis, and occasionally severe muscle weakness (Hayes et al.,
2005b). Advanced age is considered a risk factor for developing
severe WNV infection or death. The mortality rate calculated for
the recent epidemic of the disease in theU.S. is 1 in every 24 human
cases diagnosed (Kramer et al., 2008).
In horses (reviewed in Castillo-Olivares and Wood, 2004) neu-
rological disease ismanifested by approximately 10%of infections,
and is mainly characterized by muscle weakness, ataxia, paresis,
and paralysis of the limbs, as a result of nerve damage in the spinal
cord. They may also suffer from fever and anorexia, tremors and
muscle stiffness, facial nerve palsy, paresis of the tongue, and dys-
phagia, as a result of affection of the cranial nerves. A proportion
of horses infected with WNV die spontaneously or is slaughtered
to avoid excessive suffering. The mortality rate can vary between
outbreaks. For example, in the outbreak in 2000 in the Camar-
gue (France), 76 horses were affected, of which 21 died (Zeller
and Schuffenecker, 2004). In 1996 in Morocco, a WNV outbreak
affected 94 horses, of which 42 died (Zeller and Schuffenecker,
2004). Severe equine cases do not seem to predominate in older
horses, as occurs in humans (Castillo-Olivares and Wood, 2004).
Other mammals may also suffer from the disease. Rodents such
as laboratory mice and hamsters are highly susceptible, so they
can be used as experimental model of WNV encephalitis. Lemurs
and certain types of squirrels appear to be the only mammals
capable of maintaining the virus in local circulation (Rodhain
et al., 1985; Root et al., 2006). WNV can also infect other mam-
mals, including sheep, in which it causes abortions, but rarely
encephalitis (Hubalek and Halouzka, 1999). WNV has been iso-
lated from camels, cows, and dogs in enzootic foci (Hubalek and
Halouzka, 1999). The virus has been shown to infect frogs (Rana
ridibunda), which in turn are bitten by mosquitoes, so that the
existence of an enzootic cycle in these amphibians is postulated, at
least for some variants of the virus (Kostiukov et al., 1986). Out-
breaks of severe WNF with high mortality have been reported in
captive alligators and crocodiles, presumably transmitted through
feeding of contaminated meat (Miller et al., 2003). It has been
shown experimentally thatWNV can infect asymptomatically pigs
(Teehee et al., 2005) anddogs (Blackburn et al., 1989;Austgen et al.,
2004). However, guinea pigs, rabbits, and adult rats are resistant to
infection with WNV (McLean et al., 2002). Among non-human
primates, rhesus and bonnet monkeys (but not Cynomolgus
macaques and chimpanzees), inoculated withWNV develop fever,
ataxia, prostration with occasional encephalitis and tremor in the
limbs, paresis or paralysis. The infection can be fatal in these
animals.
The virus is propagated in the reservoir hosts, resulting in a
viremic phase that usually lasts no more than 5–7 days (Komar
et al., 2003). The duration and level of viremia depends on the
species infected (Komar et al., 2003). The detection of the virus
or its genetic material in serum or cerebrospinal ﬂuid in a labo-
ratory test is a proof of diagnostic value (De Filette et al., 2012).
The virus is evidenced by virological (virus isolation) or molec-
ular (RT-PCR-conventional and real-time, NASBA) techniques.
In epidemiological surveillance it is useful to detect the presence
of WNV in mosquitoes, for which they are homogenized and
analyzed using the same methods mentioned above (Trevejo and
Eidson, 2008). Speciﬁc antibodies against the virus are detectable
in blood few days after infection (Komar et al., 2003; De Filette
et al., 2012). Antibody detection is performed by serological tests
(enzyme immunoassay or ELISA, hemagglutination inhibition
or HIT) which can be conﬁrmed by more speciﬁc serological
techniques (virus-neutralization test; Sotelo et al., 2011c). Sero-
logical diagnosis of acute infection should be done by detection
of IgM antibodies in serum and/or cerebrospinal ﬂuid using an
immunocapture ELISA together with the detection of an increase
in antibody titer in paired sera taken one in the acute phase and
the other, at least 2 weeks later (Beaty et al., 1989).
The ﬁght against this disease is not straightforward because
there are no vaccines licensed for human use, and even though
www.frontiersin.org June 2012 | Volume 3 | Article 105 | 9
“fgene-03-00105” — 2012/6/12 — 19:29 — page 10 — #10
Jiménez-Clavero Animal arboviruses and global change
there are some available for veterinary use, they are efﬁcacious
to prevent disease symptoms and outcome at the individual
level but do not prevent the spread of the infection, mainly
due to the establishment of an enzootic cycle among wild
birds and mosquitoes (Kramer et al., 2008; De Filette et al.,
2012). Control methods are mainly based on prevention and
early detection of virus spread through epidemiological surveil-
lance and targeted application of insecticides and larvicides
(Kramer et al., 2008).
WEST NILE ECO-EPIDEMIOLOGY
West Nile virus is maintained in nature in an enzootic (“rural”
or “sylvatic”) cycle between its natural reservoirs, wild birds, and
ornithophilic mosquitoes acting as vectors. WNV is a generalist
pathogen, as exempliﬁed by the fact that in North America the
virus has been found infecting 284 different species of birds and
59 species of mosquitoes, although of these not more than 10
have a relevant role as vectors (Hayes et al., 2005a). This wide host
and vector ranges probably facilitate the colonization of vast areas
(Kramer et al., 2008). Primary enzootic vectors are most often
mosquitoes belonging to the genus Culex, but the virus can be
transmitted bymosquitoes of other genera (e.g.,Aedes sp.) Transo-
varial transmission of the virus has been shown to occur in at least
some Culex species (Mishra and Mourya, 2001), and this may
provide an overwintering mechanism in very cold climates. How-
ever, it is not clear whether transovarial transmission takes place
as effectively as to allow overwintering. The virus has been repeat-
edly isolated from ticks, and transmission through tick bites has
been shown experimentally (Abbassy et al., 1993; Hutcheson et al.,
2005; Formosinho and Santos-Silva, 2006). This has led to the
postulation of a role for ticks in overwintering, though this issue
needs further studies to be ascertained. WNV can also be trans-
mitted in the absence of vector, using different routes. Firstly, there
is experimental evidence of direct transmission in poultry (geese;
Banet-Noach et al., 2003). Secondly, carrion birds found infected
during periods of absence of vector suggests oral transmission,
likely through feeding on contaminated carrion (Garmendia et al.,
2000; Dawson et al., 2007). In humans, WNV transmission routes
such as intrauterine, lactogenic, and iatrogenic (through transfu-
sions and transplants), are well documented (Hayes et al., 2005b).
Occupational exposure of laboratory workers handling contami-
nated samples has also led to some cases of disease,mostly through
cuts or punctures with contaminated material (Hayes et al., 2005b;
Venter et al., 2010).
Birds are the natural reservoirs of WNV. Once infected, they
are able to replicate the virus in sufﬁcient quantity to enable its
transmission to a blood-sucking mosquito. This is not the case
of mammals, in general poorly effective as hosts for the virus
(Blitvich, 2008). Nevertheless, mammals can be susceptible to the
disease to varying degrees. Birdsmaintain the virus in a rural cycle.
In some instances a spillover from this cycle occurs which enables
the establishment of a urban cycle, producing outbreaks, some-
times of epidemic character, especially in equines and humans,
but also affecting susceptible birds.
West Nile virus is endemic in large parts of Africa, Australia,
and India, and more recently (as discussed below) arrived to
North America, where since then became endemic. In Europe,
North Africa, and the Middle East the virus has produced occa-
sional outbreaks in areas close to river basins and large wetlands
where the presence of vectors (mosquitoes) and reservoirs (birds)
provide the optimal conditions for the maintenance of the viral
cycle. Short distance spread of the virus to neighboring territo-
ries occurs most likely by birds (not necessarily migratory) acting
as carriers. The virus can occasionally be spread to long dis-
tances by wild bird migrations (Malkinson et al., 2002), although
this is not likely a frequent event (Sotelo et al., 2011b), neither
it explains all transcontinental translocations of the virus, and
signiﬁcantly, it does not explain the arrival of WNV to North
America. Long distance geographic dispersal of WNV by migrat-
ing birds is a hypothesis based mainly on circumstantial evidence,
such as the discovery of an infected ﬂock of storks in Israel in sum-
mer 1998 on their migration back to Africa from central Europe
(Malkinson et al., 2002). This hypothesis is supported by molec-
ular phylogenetic studies between isolates from recent outbreaks
in Europe and isolates from central Africa, suggesting that birds
that migrate between continents may act carrying the virus (Char-
rel et al., 2003). However, although translocation of WNV (and
also other ﬂaviviruses alike, for instance Usutu virus) by bird
migration is likely to occur, its frequency does not seem to be
as high as to explain every WNV outbreak found in Europe. On
the contrary, recent phylogenetic evidence supports that all WNV
strains isolated in the western Mediterranean area since 1996 are
a monophyletic group arising from a single common ancestor,
a strain which could have arrived to this area in 1996 or even
earlier, and since then it has been maintained in endemic circula-
tion, evolving and spreading throughout the area (Sotelo et al.,
2011b). Finally, one must not assume that the ﬂow of WNV
between Europe and Africa operates only in one direction (i.e.,
from Africa to Europe). The example previously mentioned on
migrating storks (Malkinson et al., 2002) as well as speciﬁc studies
on bird migrations and risk of introduction of pathogens (Jour-
dain et al., 2007) show thatWNV can be translocated from Europe
to Africa.
WEST NILE FEVER/ENCEPHALITIS: PAST AND PRESENT
As already mentioned, in the ﬁrst half of the twentieth century
WNFwas considered of little importance due to the benign pathol-
ogy it caused in endemic areas in equatorial Africa, where it
was ﬁrst isolated and diagnosed. However, after 1951 this con-
cept began to change, as WNV was associated to severe cases of
encephalitis, some fatal, in the ﬁrst epidemic of WNV outside
Africa, which occurred in Israel between 1951 and 1957 (Paz,
2006). The virus circulated in Egypt in the same period, where
the ﬁrst eco-epidemiological studies on WNV were carried out.
These studies characterized the enzootic cycle of WNV between
birds and mosquitoes, identifying men and horses as suscepti-
ble to the disease but not transmitting the infection (Taylor et al.,
1956). Between 1962 and 1965 there were several outbreaks of
severe illness due toWNV in the Camargue, France, affecting both
horses and humans. In 1971, WNV was isolated from mosquitoes
in southern Portugal, in the course of an epidemiological study
starting after an outbreak of encephalitis in horses, in which 29%
of the surviving horses showed seropositivity against WNV. These
sporadic outbreaks occurred not only in Mediterranean countries,
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but also in South Africa, Russia, Romania, and India. After that,
WNV in Europe remained silent for almost three decades. Its
re-emergence took place almost simultaneously in the western
Mediterranean (Algeria, 1994; Morocco, 1996; Tunisia, 1997; Italy,
1998, 2008; France, 2000; and Portugal, 2004), in central and
eastern Europe (Romania, 1996; Czech Republic, 1997; Russia,
1998; Hungary, 2004; and Austria, 2008), and in the Middle
East (Israel, 1998; revisions Hubalek and Halouzka, 1999; Murgue
et al., 2001; Sotelo et al., 2011a). Very recently, another lineage of
WNV (lineage 2) was detected in central Europe (Hungary, 2004),
extended to Austria (2008) and reached the Balkans and Greece
in 2010, where it continues its spread (Bakonyi et al., 2006; Papa
et al., 2011; Wodak et al., 2011). Almost simultaneously, in Russia
(Volga basin) a new epidemic caused by a lineage 2 WNV which is
genetically different from the variant affecting central Europe, was
observed, causing an increasing number of human cases since 2004
to date (Platonov et al., 2008). This virus has extended westward
reaching Romania in 2010 (Sirbu et al., 2011).
This new wave of WNV in Europe differed from the former in
several aspects. Firstly, its duration: this wave has extended fur-
ther in time, to the point that it is still ongoing with increasing
intensity, Since the late 1990s sporadic outbreaks have occurred
in the same locations in consecutive years. For example, in the
Camargue, France, after the ﬁrst outbreak of 2000, new out-
breaks occurred in 2003, 2004, and 2006 (Zientara et al., 2009),
and virus isolates available from these outbreaks were very closely
related phylogenetically (Sotelo et al., 2011b). This fact supports
that the virus is circulating endemically in the area since 2000
or before. In Morocco, an outbreak occurred in 2003 affect-
ing horses, similar to that produced in 1996, and again, WNV
isolates from both outbreaks show a striking similarity at the
genetic level (Sotelo et al., 2011b). In Italy an outbreak occurred
in horses in Tuscany in 1998, and 10 years later, in 2008, a serious
epidemic took place in the Po river delta, which affected hun-
dreds of horses and produced some human cases. Since then
the same area has been affected by epidemic waves of WNF
every year to date, and again, the viruses isolated in consecu-
tive years are genetically closely related (Sotelo et al., 2011b). In
Spain the ﬁrst WNV isolation took place in 2007 from golden
eagles (Jimenez-Clavero et al., 2008). Later, an outbreak affect-
ing horses and humans occurred in 2010, which continued in
2011 (OIE, 2010). Apparently, all the viruses isolated since 1996
from western Mediterranean countries (France, Italy, Morocco,
Portugal, and Spain), have a close phylogenetic relationship,
which, as noted above, supports a single introduction in the
area of a virus which has been able to remain endemic and
spread in the area during all these years (Sotelo et al., 2011b).
Secondly, the affected territory is more extended in the present
epidemic wave than in the previous one. In fact there are more
countries affected than ever in Europe. Moreover, the number
of clinical cases is higher (Sotelo et al., 2011a). Exceptionally
severe, with unusually high mortality in humans, were the epi-
demics on an “urban cycle” that occurred in 1996 in Bucharest,
Romania (about 1,000 human cases, 396 severe, 17 deaths), in
1999 in Volgograd, Russia (approximately 1,000 human cases,
40 deaths), in 1998–1999 in Israel (about 400 human cases, 35
deaths) and in Greece in 2010–2011 (336 human cases, 40 deaths;
Anonymous, 2011). Finally, the range of WNV variants circulating
in Europe is presumably higher than in the previous wave: While
all isolates analyzed from European outbreaks occurring between
1951 and 1971 belonged to lineage 1, more recent European out-
breaks have revealed not only two“classic”WNV lineages (1 and 2),
but also up to three “unusual” WNV variants, including Rabens-
burg strain or lineage 3, Krasnodar strain or lineage 4 and putative
lineage 7 from Spain.
However, the most striking change in WNV epidemiology
occurred when the virus reached the American continent in 1999.
This year the virus appeared in New York in an unexpected and
not yet well explained way. This event initiated the largest WNV
epidemic in history. The virus spread relentlessly throughout the
continent, reaching the Paciﬁc coast and Canada in 2002. Only in
the U.S. the virus has caused to date about 30,000 clinical cases
in humans of which more than 1,000 were fatal. The disease inci-
dence peaked in 2004 and since then a slow decline in clinical
cases has been observed (reviewed in Murray et al., 2010). WNV is
now considered endemic in North America, after continuous cir-
culation for 12 consecutive seasons and in its southward advance
has produced sporadic disease cases in Central America and the
Caribbean. In South America the virus has remained essentially
unnoticed, except for an outbreak in horses in Argentina in 2006
(Morales et al., 2006). The reason why WNV circulates with such
great intensity in North America, compared with other regions of
the world, currently has no explanation.
WEST NILE FEVER/ENCEPHALITIS: FUTURE TRENDS
The past 15 years have witnessed an unprecedented expansion of
a disease caused by an arbovirus, WNV, shared by animals and
man. This expansion has taken place in parallel with an increased
incidence of the disease in susceptible hosts, mostly birds, horses,
and humans (Brault, 2009). While in the Old World warning signs
were observed at the endof the last decade of the twentieth century,
the emergence of WNV in the New World triggered all alarms.
There the virus found a vast territory plenty of new naïve hosts,
and initiated one of the major arbovirus epidemics known so far.
WNV arrived in America to stay, as evidenced by the fact that the
numbers of human cases diagnosed in the last years have stabilized
at around 1,000 per year (CDC, 2011).
With regard to the relationship between climate change and the
observed expansion and increase in cases of WNF some climatic
patterns inﬂuencing local WNV circulation can be pointed out.
Firstly, high temperatures enhance virogenesis in vectors (Reisen
et al., 2006), which, along with vector abundance and competence,
promote the occurrence of WNV outbreaks. Therefore, abnor-
mally dry and hot summers, accompanied by mild winters, favor
WNV circulation, while extremely cold winters break WNV cycle
and disrupt its transmission, as illustrated in the following exam-
ple: in southern Russia (Volgograd region) after several seasons
(1997–2002) with extremely hot summers followed by mild win-
ters, the circulation of WNV was enhanced, but two upcoming
harsh winters disrupted this circulation and caused that lineage
1 WNV, responsible of the outbreaks thus far, ceased its activity
and extinguished, Two years later (2004), once more favorable
climatic conditions were restored, WNV re-emerged and caused
new clinical cases in humans, but, as mentioned above, this time
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the virus circulating did not belong to the classic lineage 1, but
to a newly introduced variant, which was identiﬁed as lineage 2
(Platonov et al., 2008). This example illustrates quite well how
WNV epidemiology is determined by climatic factors, and year-
to-year variations can lead to WNV enhancement or extinction
from an endemic area. Other well-known episodes of WNF epi-
demics occurred in scenarios of abnormally hot summers, such
as in Israel in 1998 (Paz, 2006) or New York in 1999 (Epstein,
2001). Secondly, it is known that a prolonged drought after a heavy
rainy season promotes the habitat of Culex vectors by enhanc-
ing accumulation of organic matter in suspension in standing
water. Severe drought episodes preceding by few months the onset
of WNF outbreaks have been documented in the United States
(Shaman et al., 2005). Thirdly, episodes of heavy rains, hurricanes,
ﬂoods, and overﬂow of river basins have been implicated in the
onset, or increase in outbreaks, of WNF. The WNV outbreak that
occurred in the Czech Republic in 1997 was preceded by signif-
icant ﬂooding, including severe ﬂooding of the river Vltava in
central Bohemia. In another instance, a few weeks after Hurricane
Katrina affected Louisiana and Mississippi a signiﬁcant increase
of cases of WNV neuroinvasive disease was observed in the area
(Caillouet et al., 2008).
Signiﬁcantly, all weather conditions favoring the occurrence of
WNF outbreaks, mentioned above, such as extremely hot sum-
mers, mild winters, droughts, ﬂoods, hurricanes, etc., tend to
increase in frequency and intensity according to predictions on
climate changes described in Section“Climate Change and Emerg-
ing Infectious Diseases” and listed in Table 2. However, current
WNV emergence cannot be easily explained by a single factor
such as climate change, but, more likely, a number of factors,
both abiotic and biotic, might contribute. Among these factors,
the emergence of new virus phenotypes, more virulent and/or
more transmissible and/or more adapted to their hosts and/or
vectors, could play an important role (Brault, 2009). Also, other
factors related to globalization mentioned above, such as increase
of transport, animal movements, etc., are likely to be involved in
the observed geographical expansion of WNV. Taking these factors
into account, and the observed climate trends mentioned above,
WNF will only be expected to move forward in the twenty-ﬁrst
century.
CONCLUSION
Certain arboviral animal diseases such asBTandWNFhaveunder-
gone signiﬁcant changes in their known epidemiology, gaining
unprecedented importance in the past 15 years. It is plausible that
this increase has been inﬂuenced by climate changes, although
their importance relative to other environmental factors (changes
in agriculture, land uses, etc.) is difﬁcult to estimate. Predictive
models on climate in the coming years foresee an intensiﬁca-
tion of the circumstances favoring the activity of these arboviral
pathogens. BT and WNF constitute paradigms of emerging
infectious diseases whose fate is linked to global changes.
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